Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Comparing brincidofovir and cidofovir for treating adenovirus infection in children and adults after stem cell transplantation

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Spain
  • Study of trastuzumab deruxtecan with pembrolizumab versus platinum chemotherapy with pembrolizumab for patients with untreated HER2-positive non-small cell lung cancer

    Recruiting

    1 1 1 1
    Belgium France Germany Greece Italy Poland +3
  • Study comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer

    Recruiting

    1 1 1 1
    Investigated drugs:
    Bulgaria Finland France Germany Greece Hungary +7
  • Study of Tarlatamab maintenance treatment after chemotherapy and radiation therapy in patients with limited stage small cell lung cancer who cannot receive both treatments together

    Recruiting

    1 1
    Investigated drugs:
    Spain
  • Study of MP0317 with durvalumab, gemcitabine and cisplatin combination therapy as first-line treatment for patients with advanced biliary tract cancer

    Recruiting

    1 1 1
    Investigated diseases:
    France
  • Study of THIO and cemiplimab compared to chemotherapy in patients with advanced non-small cell lung cancer who have received two previous treatments

    Recruiting

    1 1 1 1
    Hungary Poland Portugal Romania
  • Study of pembrolizumab with drug combination for first-line treatment in patients with advanced-stage classic Hodgkin lymphoma

    Recruiting

    1 1 1
    Germany
  • Study of belumosudil in children aged 1 to 18 years with moderate to severe chronic graft versus host disease requiring systemic treatment

    Recruiting

    1 1
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Spain
  • Study of RSV vaccine immune response persistence and revaccination safety in adult lung and kidney transplant recipients

    Recruiting

    1 1 1
    Investigated diseases:
    Germany Italy Spain
  • Study of elacestrant and exemestane treatment for patients with previously treated hormone receptor-positive, HER2-negative metastatic breast cancer with FES-avid lesions

    Recruiting

    1 1 1
    Italy